Efecte - First Unified Live Chat and Chatbot Pilot Customers Signed
2022-11-28 07:25:00
Redeye retains its positive view of Efecte following a solid report with a very low churn and encouraging signs from the integration of InteliWISE. Despite slightly lowering our Base Case following increasing interest rates, we believe Efecte remains a low-risk, attractively priced growth story.
Read more and download the Research Update.
Follow companies at Redeye to receive the latest equity research within Life Science and Technology.
This is a press release from Redeye - Research Powered Investment Banking.